The HIV epidemic in Ontario: 2004 update Robert S. Remis, MD, MPH, FRCPC Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences,

Slides:



Advertisements
Similar presentations
Satellite meeting on the STARHS HIV diagnostic assay in association with the 15th International AIDS Conference July 2004, Bangkok, Thailand Robert S.
Advertisements

1 Data for 2012 Priority Setting in Small Doses #1 HIV/AIDS Surveillance Data.
Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.
HIV/AIDS Prevention Committee Public Meeting November 21, 2013.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario Robert S. Remis MD Department.
Laboratories Branch, MOHLTC, IMC – 2001 The epidemiology of HIV infection among persons from HIV-endemic countries in Ontario: Update to 2002 Robert S.
Incorporating HIV and Viral Hepatitis Testing and Referral into Idaho Drug Court Programs Presented by Idaho Advisory Council on HIV and AIDS, Bebe Thompson,
1 HIV/STD Trends in Texas Sharon K. Melville, M.D., M.P.H. Texas Department of State Health Services Texas Public Health Association April 22, 2010.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Emerging Trends of HIV/AIDS in New York City Chris Williams, MPH NYC DOHMH.
HIV/AIDS in Michigan January 1, 2010 Michigan Department of Community Health HIV/STD/VH/TB Epidemiology Section Division of Communicable Diseases Bureau.
1 AIDS 2010 Vienna, July 2010 HIV/AIDS and People from Countries where HIV is endemic – Black people of African and Caribbean descent living in Canada.
HIV/STD Epidemiology in Oklahoma HIV/STD Service Division of Prevention and Preparedness Oklahoma State Department of Health.
Trends in high-risk sexual behaviour among homosexual men participating in the AIDSVAX ® B/B vaccine trial in Canada: Results to 12 months Robert S. Remis,
Overview of the State of the HIV Epidemic in Canada Regional Session on USA and Canada XIX International AIDS Conference Howard Njoo MD, MHSc, FRCPC Director-General.
HIV infection among men who have sex with men in Ontario: Analysis by race/ethnicity Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring.
Epidemiology of Hepatitis C Infection in Canada Robert S. Remis MD, MPH, FRCPC Department of Public Health Sciences University of Toronto 1st Canadian.
Wisconsin Department of Health Services HIV/AIDS Surveillance Annual Review New diagnoses, prevalent cases, and deaths through December 31, 2013 April.
HIV Declines in Young Adults in South India Rajesh Kumar, MD Prof. of Community Medicine School of Public Health Post Graduate Institute of Medical Education.
Arizona HIV/AIDS Events Per Year, Arizona Emergent HIV/AIDS Diagnoses,
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
2008 Minnesota HIV/AIDS Surveillance Report - Key Trends Lorraine Teel- Executive Director.
Bias in estimates of HIV incidence based on the detuned assay: A proposed solution Robert S Remis, Robert WH Palmer, Janet M Raboud Department of Public.
Epidemiologic overview of HIV/AIDS in Ontario and Toronto: 2004 update Robert S. Remis MD, MPH, FRCPC, Maraki Fikre Merid BSc Ontario HIV Epidemiologic.
Kevin Fenton, MD, PhD National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention August 5, 2008 Update on the US HIV/AIDS Crisis: Current Trends,
1 PHSKC 4/01 Epidemiology of HIV/AIDS Seattle-King County, WA HIV/AIDS Epidemiology Program Public Health - Seattle & King Co. (206) On the web.
Using the detuned assay to determine HIV incidence in Ontario: Results and methodologic perspectives Robert S. Remis, Carol Major, Carol Swantee, Margaret.
Washington D.C., USA, July 2012www.aids2012.org Preventing Mother to Child HIV Transmission through Community Based Approach in Nepal Nafisa Binte.
HIV Care Continuum, Georgia, United States, 2011 Presented to American Public Health Association, Annual Meeting Presented by Deepali Rane, MBBS, MPH,
Increasing HIV testing among pregnant women: Results from the Ontario HIV seroprevalence study Robert S. Remis, Carol Swantee, Maraki Fikre Merid, Robert.
Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control and Health Protection Annual data trends as of 12/31/2012 Living.
Trends in HIV incidence in Ontario based on the detuned assay: Update to October 2000 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Evelyn.
Primary HIV-1 drug resistance in Canada: Updated results from the Canadian HIV Strain and Drug Resistance Surveillance Program Canadian HIV Strain and.
HIV Care Continuum Persons Living With HIV, Georgia, 2012.
HIV infection among persons in Ontario infected through heterosexual contact Robert S. Remis, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit.
Trends in HIV incidence in Ontario based on the detuned assay: Update to December 2002 Robert S. Remis, Carol Major, Carol Swantee, Margaret Fearon, Robert.
1 Where have we failed? Findings of the Commission on AIDS in Asia Tim Brown East-West Center Modes of Transmission in the Philippines Stakeholders’ meeting.
Trends in HIV diagnoses in Ontario, 2000­2004 Robert S. Remis, Jane Njihia, Carol Swantee, Maraki Fikre Merid Ontario HIV Epidemiologic Monitoring Unit,
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2004 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases.
HIV surveillance in Northern Ireland 2013 An analysis of data for the calendar year 2012.
Mean HIV viral load among resident cases and undiagnosed in Oregon Jeff Capizzi, Epidemiologist Sean Schafer, HIV/STD/TB Medical Epidemiologist Lea Bush,
Laboratory Enhancement Study: Using the detuned assay to determine HIV incidence in Ontario October 1999 – July 2000 Robert S. Remis, Carol Major, Carol.
Chicago Department of Public Health Richard M. Daley Mayor Bechara Choucair, MD Commissioner CDPH – STI/HIV Surveillance, Epidemiology and Research Section.
HIV and STI Department The case for HIV testing A presentation for the clinical team in your practice.
HIV Infections in Utah: 2014 Epidemic Update. Cases – persons diagnosed with HIV and reported to public health Rates – cases per 100,000 populations Sex.
Marked increase in first-time HIV diagnoses in Ontario, 2002.
Katarina Grande, HIV Surveillance Coordinator Casey Schumann, HIV Epidemiologist Wisconsin Department of Health Services Statewide Action Planning Group.
Notified AIDS and HIV Infection Cases in the Seychelles: Epidemiological Trends Ministry of Health, SeychellesMinistry of Health, Seychelles –N. E. Udonwa.
1 National HIV/AIDS Commission, Barbados HIV/AIDS Research Symposium Researching who? Engaging communities in the response to HIV Winston Husbands, PhD.
Uptake of HIV testing among pregnant women in Ontario: Results from the HIV seroprevalence study to December 2000 Robert S. Remis, Carol Major, Margaret.
The HIV epidemic in Ontario: An epidemiologic update Robert S. Remis, MD, MPH, FRCPC, Department of Public Health Sciences, University of Toronto Presentation.
Update on epidemiology of HIV in New Zealand Dr Sue McAllister AIDS Epidemiology Group (AEG) University of Otago Dunedin HIV Women’s Seminar Auckland,
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
HIV Epidemiological Profile for Chicago EMA
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Global epidemiology of injecting drug use
Table 1: New HIV diagnoses, by UK country,
HIV Diagnosis and the Cascade of Care in Ontario
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Epidemiologic trends in HIV infection among men who have sex with men in Ontario: The situation in 2003 Robert S. Remis, Maraki Fikre Merid Ontario HIV.
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Epidemiologic Update on the HIV Epidemic in Ontario
Health Protection Surveillance Centre
Key Affected Populations
HIV surveillance in Northern Ireland 2018
Annual trends update: HIV, Hepatitis and STIs among MSM in Ireland (to the end of 2017) December 2018.
HIV Recency Testing in Rwanda
Presentation transcript:

The HIV epidemic in Ontario: 2004 update Robert S. Remis, MD, MPH, FRCPC Ontario HIV Epidemiologic Monitoring Unit Department of Public Health Sciences, University of Toronto Ontario HIV Treatment Network Research Conference November 25, 2004

instructional media centre, Laboratories Branch Background HIV epidemic in Ontario is unstable and dynamic HIV epidemic in Ontario is unstable and dynamic Critical to monitor trends in HIV transmission (incidence) and burden of HIV infection (prevalence) to evaluate effectiveness of prevention and assess the need for health and support services Critical to monitor trends in HIV transmission (incidence) and burden of HIV infection (prevalence) to evaluate effectiveness of prevention and assess the need for health and support services Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Organization of presentation Brief review of Ontario AIDS and HIV data Brief review of Ontario AIDS and HIV data Ontario HIV model 2003 Ontario HIV model 2003 Focus on evolving situations with respect to: Focus on evolving situations with respect to: MSM MSM IDU IDU HIV-endemic HIV-endemic Other heterosexual Other heterosexual Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Number of first-time HIV diagnoses by sex and proportion female, 1985–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch First-time HIV-positive diagnoses among males (n=21,325), Ontario, 1985–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch First-time HIV-positive diagnoses among females (n=3,409), Ontario, 1985–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Number first-time HIV diagnoses by sex Ontario, 1999–2004* * Annual, projected from first half of year

instructional media centre, Laboratories Branch Number of first-time HIV diagnoses MSM, Ontario, 1999–2004* * Annual, projected from first half of year

instructional media centre, Laboratories Branch Number of first-time HIV diagnoses for selected exposure categories, 1999–2004* * Annual, projected from first half of year

instructional media centre, Laboratories Branch Reported AIDS cases among MSM, Ontario, 1981–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Reported AIDS cases by exposure category, Ontario, 1981–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Modeled HIV prevalence and diagnoses by exposure category, Ontario, 2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch HIV incidence from detuned assay among MSM, Ontario, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch HIV incidence from detuned assay among MSM, Toronto, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch HIV incidence from detuned assay among MSM, Ottawa, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch HIV incidence from detuned assay among MSM, other regions, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch Modeled HIV prevalence among MSM Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch MSM: Epidemiologic overview 14,370 HIV-infected (61% of Ontario infections), 69% diagnosed 14,370 HIV-infected (61% of Ontario infections), 69% diagnosed New HIV diagnoses 2004 up 54% over 2001, especially in Toronto and Central West regions New HIV diagnoses 2004 up 54% over 2001, especially in Toronto and Central West regions HIV prevalence 15% (Toronto 19%, Ottawa 18%, other 8%) HIV prevalence 15% (Toronto 19%, Ottawa 18%, other 8%) prevalence up 29% (annual 5%) prevalence up 29% (annual 5%) 690 new infections in new infections in 2003 HIV incidence 0.9% (Toronto 1.1%, Ottawa 1.5%, other 0.3%) HIV incidence 0.9% (Toronto 1.1%, Ottawa 1.5%, other 0.3%) Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch HIV incidence from detuned assay among IDU, Ontario, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch HIV incidence from detuned assay among IDU, Toronto, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch HIV incidence from detuned assay among IDU, Ottawa, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch HIV incidence from detuned assay among IDU, other regions, October 1999 – December 2003 Source: Laboratory Enhancement Study

instructional media centre, Laboratories Branch Modeled HIV prevalence among IDUs Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch IDU: Epidemiologic overview 1,960 HIV-infected (8% of Ontario infections), 67% diagnosed 1,960 HIV-infected (8% of Ontario infections), 67% diagnosed New HIV diagnoses stable overall past five years, though increase in 2004 in Southwest and Northern regions New HIV diagnoses stable overall past five years, though increase in 2004 in Southwest and Northern regions HIV prevalence 5% (Ottawa 15%, elsewhere 4%) HIV prevalence 5% (Ottawa 15%, elsewhere 4%) prevalence up 8% (annual 1.5%) prevalence up 8% (annual 1.5%) 80 new infections in 2003; HIV incidence 0.2% 80 new infections in 2003; HIV incidence 0.2% Relatively reassuring Relatively reassuring Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Modeled HIV prevalence persons from HIV-endemic regions, Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch HIV-endemic: Epidemiologic overview 3,310 HIV-infected (13% of Ontario infections); 48% diagnosed 3,310 HIV-infected (13% of Ontario infections); 48% diagnosed HIV prevalence 0.8% HIV prevalence 0.8% Most HIV-infected persons in Toronto (75%) and Ottawa (15%) Most HIV-infected persons in Toronto (75%) and Ottawa (15%) prevalence up 86% (annual 13%) prevalence up 86% (annual 13%) New HIV diagnoses increased 1999 (160) to 2002 (280) then decreased somewhat (230 in 2004) New HIV diagnoses increased 1999 (160) to 2002 (280) then decreased somewhat (230 in 2004) 330 new HIV infections in 2003 (imported & Canada) 330 new HIV infections in 2003 (imported & Canada) Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Modeled HIV prevalence other persons infected heterosexually, Ontario, 1977–2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Heterosexual : Epidemiologic overview 3,310 HIV-infected (14% of Ontario infections), 48% diagnosed 3,310 HIV-infected (14% of Ontario infections), 48% diagnosed HIV prevalence up 64% (annual 10%) HIV prevalence up 64% (annual 10%) 2000 to 2004, HIV diagnoses increased 70%; increased in most regions but especially Central West (+202%), Southwest (+160%) and Toronto (+74%) 2000 to 2004, HIV diagnoses increased 70%; increased in most regions but especially Central West (+202%), Southwest (+160%) and Toronto (+74%) 320 new HIV infections in new HIV infections in 2003 Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Limitations Populations at risk not well characterized Populations at risk not well characterized Adjustments for HIV diagnoses, AIDS cases and HIV-related mortality subject to uncertainty Adjustments for HIV diagnoses, AIDS cases and HIV-related mortality subject to uncertainty Data on HIV incidence limited and biased Data on HIV incidence limited and biased Despite challenges, triangulation allows obtaining plausible estimates for HIV incidence and prevalence Despite challenges, triangulation allows obtaining plausible estimates for HIV incidence and prevalence Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Conclusions Good news: AIDS incidence and mortality decreasing and situation reassuring among IDUs Good news: AIDS incidence and mortality decreasing and situation reassuring among IDUs Overall, HIV epidemic in Ontario unstable Overall, HIV epidemic in Ontario unstable HIV prevalence up 36% past 5 years (17,400 to 23,600) HIV prevalence up 36% past 5 years (17,400 to 23,600) Concerning in MSM, HIV-endemic and heterosexual Concerning in MSM, HIV-endemic and heterosexual Sustained HIV transmission in these groups Sustained HIV transmission in these groups Dr. Robert S. Remis Public Health Sciences, University of Toronto

instructional media centre, Laboratories Branch Acknowledgements Frank McGee, AIDS Bureau, Ontario Ministry of Health and Long Term Care (MOHLTC) Frank McGee, AIDS Bureau, Ontario Ministry of Health and Long Term Care (MOHLTC) Carol Swantee, HIV Laboratory, MOHLTC Carol Swantee, HIV Laboratory, MOHLTC Jane Njiah, FSO, PHAC / MOHLTC Jane Njiah, FSO, PHAC / MOHLTC Maraki Fikre Merid, University of Toronto Maraki Fikre Merid, University of Toronto Lorraine Schiedel, Public Health Branch, MOHLTC Lorraine Schiedel, Public Health Branch, MOHLTC Ontario HIV Treatment Network (OHTN) and Health Canada for funding Laboratory Enhancement Study Ontario HIV Treatment Network (OHTN) and Health Canada for funding Laboratory Enhancement Study